Theriva Biologics TOVX
NYSE TOVX
$0.23 +0.01 (+2.40%)
As of: Oct 1, 2026 · 3:56 PM EDT

Theriva Biologics (TOVX) Change in Receivables (2010 - 2012)

Updated

Theriva Biologics' Change in Receivables came in at -$14,000 for FY2012, compared with $480,000 in FY2011.

Analysis

Theriva Biologics (TOVX) Change in Receivables (2010 - 2012) Analysis & Trends

  • Per Business Quant, earlier years put Change in Receivables at $480,000 in FY2011 (+9.6%) and $438,000 in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.35 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.37 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.09 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 333.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 140.20 Mn
10 Theriva Biologics 10.56 Mn 10.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 -19,000.00
Jun 30, 2012 -38,000.00
Mar 31, 2012 43,000.00
Dec 31, 2011 69,000.00
Sep 30, 2011 116,000.00
Jun 30, 2011 184,000.00
Mar 31, 2011 111,000.00
Dec 31, 2010 -169,225.00
Sep 30, 2010 453,651.00
API Access

Theriva Biologics Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=TOVX&period=max&api_key=YOUR_API_KEY